Applying machine learning techniques to the identification of late-onset hypogonadism in elderly men

SpringerPlus

Volumn 5, Issue 1, 2016, Pages

  Lu, Ti ^a   Hu, Ya Han ^b   Tsai, Chih Fong ^c   Liu, Shih Ping ^d   Chen, Pei Ling ^d  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

^c NATIONAL CENTRAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Classification; Data mining; Late onset hypogonadism (LOH); Prediction

Indexed keywords

EID: 84975801338     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-016-2531-8     Document Type: Article

References (27)

1. Araujo AB, O’Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM et al (2004) Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab 89(12):5920–5926
2. Clapauch R, Carmo AM, Marinheiro L, Buksman S, Pessoa I (2008) Laboratory diagnosis of late-onset male hypogonadism andropause. Arq Bras Endocrinol Metabol: ABE&M 52(9):1430–1438
3. Cunningham GR (2006) Testosterone replacement therapy for late-onset hypogonadism. Nat Clin Pract Urol 3(5):260–267
4. Emmelot-Vonk MH, Verhaar HJJ, Nakhai-Pour HR, Grobbee DE, van der Schouw YT (2011) Low testosterone concentrations and the symptoms of testosterone deficiency according to the Androgen Deficiency in Ageing Males (ADAM) and Ageing Males’ Symptoms rating scale (AMS) questionnaires. Clin Endocrinol 74(4):488–494
5. Freund Y, Schapire RE (1997) A decision-theoretic generalization of on-line learning and an application to boosting. J Comput Syst Sci 55(1):119–139
6. Gooren L (2008) Can the administration of testosterone to men with late-onset hypogonadism be discontinued? J Mens Health 5(4):366–373
7. Han J, Kamber M, Pei J (2011) Data mining: concepts and techniques. Elsevier, Amsterdam
8. Haren M, Chapman I, Coates P, Morley J, Wittert G (2005) Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status. Age Ageing 34(2):125–130
9. Heinemann LAJ (2005) Aging Males’ Symptoms scale: a standardized instrument for the practice. J Endocrinol Invest 28:34–38
10. Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W (1992) A new aging males’ symptoms’ rating scale. Aging Male 2(2):105–114
11. Iwamoto T, Yanase T, Horie H, Namiki M, Okuyama A (2009) Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan. Int J Urol 16(2):168–174
12. Jones TH (2009) Late onset hypogonadism. BMJ 338(feb13_1):b352
13. Jones TH (2010) Andrology: identifying late-onset hypogonadism in older men. Nat Rev Urol 7(11):599–601
14. Kalinchenko S, Vishnevskiy EL, Koval AN, Mskhalaya GJ, Saad F (2008) Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 11(2):57–61
15. Kalyani RR, Dobs AS (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 14(3):226–234
16. Karazindiyanoğlu S, Cayan S (2008) The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 11(3):146–149
17. La Vignera S, Calogero AE, D’Agata R, Di Mauro M, Tumino S, Condorelli R et al (2008) Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism. Minerva Endocrinol 33(3):159–167
18. Liu KE, Lo C-L, Hu Y-H (2014) Improvement of adequate use of warfarin for the elderly using decision tree-based approaches. Methods Inf Med 53(1):47–53
19. Miner MM, Seftel AD (2007) Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead? Int J Clin Pract 61(4):622–632
20. Myon E, Martin N, Taïeb C, Heinemann LAJ (2009) Experiences with the French Aging Males’ Symptoms (AMS) scale. Aging Male 8(3–4):184–189
21. Quinlan JR (1987) Simplifying decision trees. Int J Man Mach Stud 27(3):221–234
22. Rosano GMC, Sheiban I, Massaro R, Pagnotta P, Marazzi G, Vitale C et al (2006) Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 19(2):176–182
23. Tancredi A, Reginster J, Schleich F, Pire G, Maassen P, Luyckx F et al (2004) Interest of the androgen deficiency in aging males (ADAM) questionnaire for the identification of hypogonadism in elderly community-dwelling male volunteers. Eur J Endocrinol 151(3):355–360
24. Valenti G, Gontero P, Saccò M, Fontana F, Strollo F, Castellucci A et al (2009) Harmonized Italian version of the Aging Males’ Symptoms scale. Aging Male 8(3–4):180–183
25. Wang C, Nieschlag E, Swerdloff R, Behre HM, Hellstrom WJ, Gooren LJ et al (2008) ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Int J Impot Res 21(1):1–8
26. Wu FCW, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW et al (2008) Hypothalamic–pituitary–testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab 93(7):2737–2745
27. Wu FCW, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD et al (2010) Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med 363(2):123–135